Build your professional network on facebook via our app Go to app
 
 
 
Created by : Nilesh Jain, Project Manager, A Leading Media/Telecom Co.  | 03 29 2010 08:35:16 +0000
Industry : PharmaceuticalsFunctional Area : India(Markets)
Activity:  86 views;  last activity : 07 06 2010 20:18:09 +0000

Request all to look at these two articles from today's newpapers...

DNAIndia-Money: 29Mar10: "Same medicine, different price"

...still, the NPPA has charged companies like Cipla, Ranbaxy, Dr Reddy’s Laboratories and Wyeth for overcharging. The NPPA is trying to recover Rs2,000 crore in overcharged amount. according to S Srinivasan, managing trustee of Locost, a Baroda-based NGO, cost differentials between brands have got nothing to do with the quality of the medicines, but occur due to marketing and promotional expenses.

*******************************
TimesOfIndia: 29Mar10: "Doctors making huge profits on vaccines"

Pharma Cos Offer Them New Products At Very Cheap Rates

Vaccines are meant to help prevent diseases.But they could also have another vital use as an alternative and significant source of income for doctors...

...Interestingly,the vaccines being offered at hugely discounted prices to doctors are not those that are recommended for universal immunisation.Such aggressive promotion is for new and expensive vaccines and combination vaccines whose use in the Indian context is not well established in terms of epidemiological rationale or cost benefit analysis,says Dr Lodha.

*******************************

We have regulators at both the industries levels, ie. TRAI (Telecom Regulatory Authority of India) & NPPA (National Pharmaceutical Pricing Authority). Should we assume both the regulators must be equally strong in there domain/work areas?

But there is a huge disparity? In last 15/20 years, except electronic goods, cars, pepsi/cola & telecommunication everything is increased manifolds. Do you think government should concentrate more on life saving items/commodity rather than telecommunication and other stuffs? What is most required and desired of?

 
Share
 
 
  Rate : 
 
 
National Pharmaceutical Pricing Authority (NPPA) Vs Telecom Regulatory Authority of India (TRAI)
2
 
 
 
 
0
3
0
Support   Support
Top Argument
1
0

NPPA had marked around 1000 life saving drugs under price regulation.  But it is still to cover more than 90% of companies/drugs under its control.  While TRAI has handful of companies to deal with.  Is this an only advantage  to TRAI?   We certainly need a many times strong regulator to control this white collared crime by doctors and pharma companies. Government must prioritize between drugs and mobiles.


By Nilesh Jain, Project Manager, A Leading Media/Telecom Co.  03 29 2010 09:15:30 +0000
 
0
0

Anita, thanks for support.

Eeven myself is being in telecom, I put it across just to make members aware and seek an opinion.  Comparison came to my mind because of following few reasons:

1) Both are government bodies working as industry regulators for fare practices in pricing and has to deal with handful of companies.

2) Both are suppose to do similar jobs to ensure consumer benefits.  Ones success record is far high while other's is much poor.  (Certainly, success of one cannot be a cause of failure for other.)

3) Drugs are any time more important than a telephone call, as it deals with consumer's life and pocket in bad times.

4) Progress & control of TRAI is much more significantly visible, beneficial to end consumer and hence appreciable.  Many of the people are aware of TRAI.

5)  NPPA remained unnoticed, may be due to lack of vision along with above stated reasons.

Additionally, you may check the following link to know how day-light robberies are done by great indian/mnc pharma companies.

http://epaper.dnaindia.com/bigwin.aspx?url=EpaperImages%5C30032010%5Cproicwarsssss-large.jpg&eddate=3/30/2010&pageno=3&edition=9&prntid=113373&bxid=97&pgno=3

DNA-30Mar2010

Thanks


By Nilesh Jain, Project Manager, A Leading Media/Telecom Co.  | 03 31 2010 07:10:27 +0000
1
0

Nilesh thanks for initiating, yes even I have come across such incidents. There is not constant prices for the drugs. So it would be better if there is a common price strategy across India. This will benefit the people and the government too.

So regulation should be made more stronger in pharma sector. But can you tell me why your are comparing it with telecom industry.  :)       


By Anita Rai, Marketing Manager, Leading Pharmaceutical Co.  | 03 30 2010 09:26:37 +0000
Leading Recruitment Firm
Leading Recruitment Firm
Viewers also viewed
There is a talk that MFI's could cause a bubble in the country the only way to prevent this is...
 
60 referals 11 arguments, 252 views
See at the link below. http://en.wikipedia.org/wiki/Simon–Ehrlich_wager
 
271 referals 5 arguments, 388 views
A new proposal is being made from India's drug regulator where the ads of morning after pills...
 
218 referals 74 arguments, 3210 views
more...  
Recent Knowledge (2)
WE HAD A GOOD NUMBER OF INVENTORS WITH GREATER VISION ABOUT THE SOCIETY. INVENTORS HERE NEED NOT...
 
2 referals 2 arguments, 128 views
I am associate of prajapati association and i am working for BJP from year 2005 to till date....
 
0 referals 3 arguments, 140 views
more...  
More From Author
Mr Rajeev, the clip not necessary to be true. If so, then Anna's village would have not got the awards. No people from other country would have visited there. For the moment can we forget past and fight unitedly for the cause at least? Every...
There are many ways to look at it. But the need-of-hour is we need a strong anti-corruption laws to deter it. We may not be able to make it 100% clean, but certainly can be reduced to a great extent, if laws are stringent. Today, bureaucrats &...
There are many ways to look at it. But the need-of-the-hour is we need a strong anti-corruption laws to deter it. We may not be able to make it 100% clean, but certainly can be reduced to a great extent, if laws are stringent. Today, bureaucrats &...
more...